Author:
Sen Zhang,Weida Wang,Li Yan,Zhaojun Li,Nina Xue,Xiaoguang Chen
Funder
CAMS Innovation Fund for Medical Sciences
Beijing Municipal “Ten Diseases and Ten Drugs”
Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study
Reference41 articles.
1. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy;Alvarez-Prats;Nephrol., Dial., Transplant.: Off. Publ. Eur. Dial. Transplant. Assoc. - Eur. Ren. Assoc.,2012
2. An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney;Arias;Am. J. Physiol. Ren. Physiol.,2016
3. Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment;Aunapuu;Medicina,2003
4. Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy;Azegami;Hypertens. Res.: Off. J. Jpn. Soc. Hypertens.,2012
5. TGF-beta signaling in renal disease;Bottinger;J. Am. Soc. Nephrol.: JASN,2002
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献